Aeglea Biotherapeutics shares owned by Emerald Advisers
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Emerald Advisers
from 13F filings
Historical chart of Emerald Advisers investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Emerald Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.2M | 549k | 16.76 |
| 2025-06-30 | $8.5M | 566k | 14.97 |
| 2025-03-31 | $8.8M | 548k | 16.14 |
| 2024-12-31 | $13M | 547k | 23.28 |
| 2024-09-30 | $8.6M | 293k | 29.41 |